Category: Revive Therapeutics

Revive Therapeutics Announces Initiation of Research Discovery Program of Cannabinoid-Based Therapies Targeting Liver Diseases

TORONTO, ONTARIO–(Marketwired – March 1, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced the initiation of the...

Revive Therapeutics Ltd. Announces Results for the Three and Six Months Ended December 31, 2016

TORONTO, ONTARIO–(Marketwired – February 28, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(RVVTF), today announced its results for the three and six months ended December 31, 2016. The unaudited condensed interim financial statements and management’s discussion and analysis...

Revive Therapeutics Announces Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases

TORONTO, ONTARIO–(Marketwired – Feb. 22, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), today announced the Company has entered into a term sheet agreement with InMed Pharmaceuticals Inc. (“InMed”) for the discovery and development of cannabinoid-based therapies targeting...